| Report ID | 278886 |
| Drug Identification Number | 02141450 |
| Brand name | 20% PROSOL |
| Common or Proper name | test |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | PROLINE LYSINE THREONINE TRYPTOPHAN DL-METHIONINE L-ASPARTIC ACID SERINE PHENYLALANINE GLYCINE ISOLEUCINE VALINE ALANINE LEUCINE GLUTAMIC ACID ARGININE TYROSINE HISTIDINE |
| Strength(s) | 1.34G 1.35G 0.98G 0.32G 0.76G 0.6G 1.02G 1G 2.06G 1.08G 1.44G 2.76G 1.08G 1.02G 1.96G 0.05G 1.18G |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 12/ml |
| Anatomical Therapeutical Chemical (ATC) code | B05BA |
| Anatomical Therapeutical Chemical (ATC) description | I.V. SOLUTIONS |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | 2026-03-04 |
| Actual discontinuation date | 2026-07-05 |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-25 | French | Compare |
| v1 | 2026-02-25 | English | Compare |
Showing 1 to 2 of 2